HBSP (USA)
-
Building an Integrated Biopharma Company: Crucell (A)
Hamermesh, Richard G.; Van Der Steen, Marianne; Harmeling, Susan S.Case HBS-815085-EEntrepreneurshipBy 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space, had begun to attract the attention of much larger pharmaceutical companies. While there was much appeal to working with these companies, these relationships could also challenge Cruc...Starting at €8.20
-
Mothers of Rotterdam: Scaling a Social Services Program in the Netherlands
Winig, Laura; Boatright Wilson, JulieCase HBS-KS1269-EEntrepreneurshipBoard Chair Nanne Boonstra was about to learn the details of a scaling strategy proposal for Mothers of Rotterdam, a fledgling social service program that helped the city's disadvantaged pregnant women. Boonstra's employer, a venture philanthropy foundation that was funding the program, was interested in whether it was feasible to scale the pilot program throughout Rotterdam. Other stakeholders hoped the program might be replicated elsewhere in t...Starting at €8.20
-
Mothers of Rotterdam: Scaling a Social Services Program in the Netherlands, Teaching Plan
Boatright Wilson, JulieTeaching Note HBS-KS1270-EEntrepreneurshipTeaching note for case KS1269.Starting at €0.00
-
Building an Integrated Biopharma Company: Crucell (B)
Hamermesh, Richard G.; Van Der Steen, Marianne; Harmeling, Susan S.Case HBS-815086-EEntrepreneurshipThe Crucell (B) case updates events at Crucell since 2009. In September, 2009, Johnson & Johnson acquired 18% of Crucell for $400 million. This investment was part of a business development deal. Subsequently, in 2012, Johnson & Johnson acquired Crucell for $2.8 billion.Starting at €5.74